Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Three-way Crossover Bioequivalence Study of Pediatric Formulations of Lamivudine/Zidovudine/Nevirapine Using Healthy Adult Volunteers

NCT01469520 is registered in ClinicalTrials.gov with Elim Pediatric Pharmaceuticals Inc. as lead sponsor.

NCT NCT01469520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01469520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Three-way Crossover Bioequivalence Study of Pediatric Formulations of Lamivudine/Zidovudine/Nevirapine Using Healthy Adult Volunteers
Lead sponsor
Elim Pediatric Pharmaceuticals Inc.
Phase
Phase 1
Overall status
Unknown status
Start date
October 31, 2010
Completion date
December 31, 2011
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aids, hiv